Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We conclude that multigene panel testing for familial melanoma is appropriate considering the additional 4% diagnostic yield in non-CDKN2A/CDK4 families.
|
30414346 |
2019 |
Hereditary Melanoma
|
0.500 |
Biomarker
|
disease |
BEFREE |
CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
|
29774366 |
2018 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We carried out a mutational analysis of CDKN2A, CDK4 exon 2, POT1 p.S270N, MITF exon 10, MC1R, and the TERT promoter in 106 high-risk patients with familial melanoma (FM) and sporadic multiple primary melanoma (spMPM) from Central Italy and evaluated mutations according to the clinicopathological characteristics of patients and lesions.
|
28146043 |
2017 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Forty-eight patients have met the criteria of the Italian Society of Human Genetics (SIGU) for the diagnosis of familial melanoma and were screened for CDKN2A and CDK4 mutations.
|
26650572 |
2016 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Three hundred and four consecutive single primary melanoma (SPM), nine familial melanoma (FM) and seven multiple primary melanoma cases (MPM) were assessed for sequence variants in exons 1α, 1β and 2 of CDKN2A and exon 2 of CDK4.
|
21801156 |
2011 |
Hereditary Melanoma
|
0.500 |
Biomarker
|
disease |
BEFREE |
To this end, we have developed a multiplex bead-based assay for high-throughput CDKN2A/CDK4 genotyping in the context of familial melanoma.
|
21085193 |
2011 |
Hereditary Melanoma
|
0.500 |
Biomarker
|
disease |
BEFREE |
Melanoma susceptibility genes CDKN2A and CDK4 play a role in the development of melanoma, especially among some familial melanoma kindreds.
|
18025917 |
2007 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6.
|
17909018 |
2007 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations of the CDKN2A and CDK4 genes explain a significant proportion of familial melanoma.
|
17505264 |
2007 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The familial melanoma syndromes are associated with germline mutations in three highly penetrant gene products: p16, alternate reading frame, and cyclin-dependent kinase 4.
|
16462187 |
2006 |
Hereditary Melanoma
|
0.500 |
Biomarker
|
disease |
BEFREE |
In the past several years, two major susceptibility genes for melanoma, CDKN2A and CDK4, have been identified, but the two genes together account for a minority of familial melanoma.
|
12789279 |
2003 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Rarity of CDK4 germline mutations in familial melanoma.
|
11828258 |
2002 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
This mutation (replacement of Arg24 by Cys) was first found in patients with hereditary melanoma and renders Cdk4 insensitive to INK4 inhibitors.
|
11726500 |
2001 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Analysis of the CDKN2A and CDK4 genes and HLA-DR and HLA-DQ alleles in two Spanish familial melanoma kindreds.
|
11243640 |
2001 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
This mutated CDK4 acts as a dominant oncogene and has been found in both sporadic and familial melanoma.
|
9712735 |
1998 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In summary, our results show frequent involvement of the p16 gene in familial melanoma and confirm the role of the CDK4 gene as a melanoma-predisposing gene.
|
9425228 |
1998 |
Hereditary Melanoma
|
0.500 |
Biomarker
|
disease |
BEFREE |
CDKN2A (9p21) and CDK4 (12q13) have been identified as melanoma susceptibility genes in certain familial melanoma (FM) kindreds.
|
9258659 |
1997 |
Hereditary Melanoma
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Moreover, a CDK4 gene mutation, responsible for a functional resistance of CDK4 kinase to p16 inhibitory activity, has been described to occur in some cases of familial melanoma.
|
9036865 |
1997 |
Hereditary Melanoma
|
0.500 |
Biomarker
|
disease |
BEFREE |
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
|
8710906 |
1996 |
Hereditary Melanoma
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hereditary Melanoma
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
|
|
|